20 September 2023 : Clinical Research
Early Echocardiography and ECG Changes Following Radiotherapy in Patients with Stage II-III HER2-Positive Breast Cancer Treated with Anthracycline-Based Chemotherapy with or without Trastuzumab-Based Therapy
Radu Valeriu Toma- A Study design/planning
- B Data collection/entry
- C Data analysis/statistics
- G Funds collection
- A Study design/planning
- D Data interpretation
- *Corresponding author: [email protected]
- *Corresponding author: [email protected]
- C Data analysis/statistics
- D Data interpretation
- E Preparation of manuscript
- F Literature analysis/search
- A Study design/planning
- B Data collection/entry
- C Data analysis/statistics
- D Data interpretation
- E Preparation of manuscript
- F Literature analysis/search
DOI: 10.12659/MSM.941754
Med Sci Monit 2023; 29:e941754
Figure 6 The association of changes in echocardiographic semiology with the decrease in EF ≥10% (as a predictor) during monitoring, with treatment modalities, and with the pre-existence of some comorbidities (cardiac preconditioning). The 95% confidence intervals are plotted in a logarithmic scale (from 1 to 1000) for OR and (from 1 to 10) for RR. TT is targeted therapy, ie, anti-HER2 therapy.